BioAtlas Enzyme Intelligence

Enzymes mapped as mechanism-layer intelligence.

BioAtlas maps enzyme biology as structured research intelligence across cancer relevance, cellular targets, inflammation, epigenetics, nutrient and hormone dependencies, tissue localisation, ADME/BBB behaviour, stemness, regeneration, receptors, pathways, synergies, miRNA, ECS modulation, non-cancer issues, evidence provenance, and six-layer biological systems-state interpretation. The public enzyme intelligence page introduces the framework safely. Deeper graph workbenches, raw generated datasets, export systems, and protected intelligence tools remain inside reviewed-access BioAtlas environments.

1,724
Enzyme atlas
38
Families
6 layers
Model

Why enzymes matter

Enzymes are not just catalogue entries. They are biological switches that connect metabolism, signalling, immune tone, cancer behaviour, detoxification, repair, epigenetics, ECS regulation, inflammation, tissue context, and mechanism interpretation. Many biomedical platforms organise around genes, drugs, trials, markets, or disease labels. BioAtlas adds an enzyme-first mechanism layer: a way to understand how enzymes participate in biological terrain and how that terrain differs across clients, systems, pathways, and evidence contexts.

+

Mechanism

Enzymes as biological switches

Enzymes can alter signalling state, catalytic flow, redox behaviour, pathway routing, tissue response, and biological timing.

Terrain

Context beyond a single target

BioAtlas maps enzymes across cancer, inflammation, epigenetics, nutrients, hormones, tissue, ECS, miRNA, ADME/BBB, and non-cancer issues.

Graph

From dataset rows to relationship intelligence

Internal BioAtlas systems connect enzyme cards, field signatures, relationship profiles, evidence provenance, and confidence layers.

Six-layer enzyme systems-state model

BioAtlas organises enzyme intelligence through a six-layer systems-state model. This framework allows enzymes to be compared by biological terrain instead of only by isolated gene names, single pathways, or static disease labels.

+

Bioelectric

Charge, membrane state, receptors, and tissue excitability

The signalling layer describes how enzymes participate in receptor activity, barrier behaviour, inflammatory signalling, membrane transport, tissue localisation, and broader systems coordination.

Biophotonic

Redox-light, mitochondria, ROS, cofactors, and energy state

The redox-regulatory layer maps mitochondrial signalling, oxidative pressure, flavin/heme/NAD-linked systems, cofactor biology, and energy-state behaviour.

Oscillatory

Rhythm, feedback, oscillatory coordination, and cyclic signalling

The oscillatory/resonance layer describes biological timing: hormone cycling, ECS tone, inflammatory pulses, phosphorylation waves, feedback loops, and state transitions.

Redox / Bioenergetics

Electron transfer, proton transfer, catalytic precision, and redox state

The redox/bioenergetic layer is a biochemical annotation layer for enzyme catalysis, electron/proton movement, cofactor dependence, redox state, and conformational precision.

Morphogenic

Tissue architecture, stemness, repair, regeneration, and biological form

The geometric/morphogenic layer maps enzymes involved in tissue shape, extracellular matrix behaviour, regeneration, stemness, tumour architecture, cell death morphology, and repair logic.

Regulatory

Gene expression, miRNA, epigenetics, signalling logic, and memory

The informational/regulatory layer describes how enzymes influence biological instruction flow: chromatin state, miRNA regulation, pathway routing, transcriptional logic, and regulatory memory.

Professional wording boundary

The systems-state model is a physics-informed systems annotation framework. It does not claim clinical diagnosis, treatment selection, or deterministic prediction. It organises enzyme biology through field-like dimensions that help compare mechanism, signalling, tissue context, catalytic state, and biological systems behaviour.

Dataset architecture

The enzyme intelligence layer is built from a standardised databar architecture. Each enzyme can be represented across repeated fields, allowing comparison, scoring, graph traversal, client interpretation, and evidence-backed context generation.

+
Enzyme groupingsEnzymeRelevant cancersCells targetedInflammatory markersEpigenetic modifiersNutrient dependenciesHormone interactionsTissue localisationADMEBBB permeabilityStem cell pathwaysRegenerative capacityReceptorsPathwaysSynergistic pathwaysSynergy referencesmiRNA modulationECS modulationNon-cancer issues

Graph intelligence

Inside protected BioAtlas environments, enzyme records can connect to relationship profiles, internal card tabs, systems-state signatures, graph coverage, confidence scoring, and evidence provenance. The public page introduces the concept without exposing raw datasets, generated files, export systems, or internal graph workbenches.

+

Internal graph logic

Enzymes can be mapped to intelligence cards, relationship counts, internal tab density, systems-state signatures, family coverage, pathway context, and confidence layers.

Public-safe framing

Public visitors see the architecture and value proposition. Protected users, clients, and enterprise reviewers can request access to deeper evidence-backed systems.

Evidence and provenance

BioAtlas treats evidence as a first-class layer. Enzyme intelligence can be connected to provenance fields, source kinds, citation-like entries, evidence objects, and dataset source paths. This supports transparency, review, and commercial diligence without turning the public site into a raw data dump.

+

Evidence

Citation-like entries

Evidence-like fields and provenance metadata support review of where enzyme intelligence came from.

Provenance

Source kinds and source files

BioAtlas can distinguish manifest, overlay, xlsx, bridge, pathway, cancer, ECS, synergy, and mechanism source families.

Confidence

Evidence-weighted field signatures

Internal systems can combine systems-state scores with evidence counts to show whether a signature is sparse, developing, supported, or strong.

Who enzyme intelligence helps

The enzyme intelligence engine is designed as a flexible mechanism layer. Different client groups see different value depending on whether they need education, target context, diligence, mechanism review, licensing, or enterprise integration.

+

Clinics

Research-safe biological context

Clinics can use enzyme intelligence as a research-support context layer for complex biological terrain, not as diagnosis, prescribing, or treatment selection.

Biotech

Target prioritisation and mechanism mapping

Biotech teams can use enzyme-first intelligence to explore target context, family coverage, mechanism hypotheses, ADME/BBB constraints, synergy logic, and validation priorities.

Pharma

Mechanism-layer portfolio intelligence

Pharma teams can use enzyme intelligence as a mechanism layer beneath pipeline, trial, market, and competitive intelligence systems.

Commercial buyer lanes

One enzyme engine, multiple commercial routes.

BioAtlas enzyme intelligence can be packaged differently depending on buyer need: public education, professional context, biotech target review, pharma mechanism intelligence, diligence review, enterprise graph/API integration, or AI-rights licensing.

The value increases with rights. View-only access, professional use, exports, API access, AI retrieval, embedding, model training, sublicensing, territorial exclusivity, and acquisition rights should remain separate commercial layers.

Clinic

Clinic Context Layer

Research-safe enzyme terrain for inflammation, ECS signalling, tissue context, miRNA, pathway logic, non-cancer issues, and biological systems review.

Outputs: enzyme terrain summaries, context briefs, research-support interpretation, and professional review prompts.

Biotech

Biotech Target Lens

Target prioritisation support across enzyme families, validation planning, ADME/BBB constraints, synergy context, pathway density, and systems-state signatures.

Outputs: target shortlists, mechanism maps, validation context, and field-state prioritisation views.

Pharma

Pharma Mechanism Lens

Mechanism-layer intelligence for portfolio review, target liability, repurposing hypotheses, pathway convergence, combination logic, and biological differentiation.

Outputs: mechanism review packs, target-liability briefs, combination hypotheses, and portfolio-context maps.

Enterprise

Graph / API Layer

Structured enzyme graph access, evidence summaries, systems-state profiles, relationship context, API integration, and controlled data-rights boundaries.

Outputs: graph/API access options, custom dataset slices, integration briefs, and enterprise review pathways.

Diligence

Diligence Pack

Buyer-facing proof layer showing dataset architecture, evidence posture, protected graph depth, systems-state modelling, and commercial review readiness.

Outputs: diligence summaries, protected-depth previews, evidence posture notes, and data-room pathway framing.

Rights

Licensing / AI Rights

Separates view-only access, export rights, API rights, AI retrieval, embedding, training, sublicensing, territory, exclusivity, and acquisition pathways.

Outputs: rights schedules, AI-boundary language, licence packaging, and commercial pathway definitions.

Access and licensing

Public visitors can learn the framework. Deeper enzyme graph systems, dataset exports, AI retrieval rights, API access, diligence packs, and enterprise integration remain governed by reviewed access, commercial terms, and explicit rights boundaries.

+

Request reviewed enzyme intelligence access

Protected enzyme graph workbenches, raw generated datasets, export systems, API routes, and enterprise evidence layers remain sealed behind reviewed access. Use the public access route to request appropriate review.

Request access